Non-Toxic Flavonoids of Artemisia annua can be used as Anti-Cancer Compounds: A Computational Analysis

Flavonoids of Artemisia annua for Cancer Treatment

Abstract

Objective: To identify potential flavonoids of Artemisia annua effective against cancer using computational
approaches.
Study Design: Computational approaches were used to predict the anticancer activity of flavonoids through
CDRUG, comparing it with the standard anticancer drug, followed by determining physiochemical properties
and toxicity prediction of the selected flavonoids.
Place and Duration of Study: The study was carried out at Department of Bioinformatics and Biosciences of
Capital University of Science and Technology (CUST) Islamabad, from December 2017 to July 2018.
Materials and Methods: The flavonoids of Artemisia annua L were downloaded and computational techniques such as similarity search, toxicity prediction, targets identification etc. were applied to investigate their anti-cancer activities.
Results: Luteoline, Cirsilineol, Cirsiliol, Eupatorin, Crisimaritin and Artemetin showed positive results among all
the tested flavonoids. These compounds have the potential to replace anti-cancer drugs because of anti-cancer
activity, toxicity against cancer cells and similarity with approved anti-cancer agents.
Conclusion: The screened compounds are good candidate for future drugs to be used against cancer. However,
this is an in-silico study requiring further laboratory and enzymatic assays confirmation, which can be done invitro in future.